Fuji Pharma Co., Ltd.(JP:4554)
¥1,871.00+14.00 (+0.75%)
JP:4554
Fuji Pharma Co., Ltd. financials statements
¥1,871.00
At close:+14.00 (+0.75%)
Want to see JP:4554 full AI Analyst Report?
Fuji Pharma Co., Ltd. (4554) Income Statement
0 Followers
Fuji Pharma Co., Ltd. Income Statement
Last quarter (Q4 2026), Fuji Pharma Co., Ltd.'s total revenue was ¥17.00B, an increase of 15.49% from the same quarter last year. In Q4, Fuji Pharma Co., Ltd.'s net income was ¥1.01B. See Fuji Pharma Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Sep 26 | Sep 25 | Sep 24 | Sep 23 | Sep 22 |
|---|---|---|---|---|---|
| ¥ 62.39B | ¥ 51.68B | ¥ 46.14B | ¥ 40.89B | ¥ 35.43B | |
| ¥ 22.77B | ¥ 19.29B | ¥ 16.51B | ¥ 15.37B | ¥ 13.62B | |
| ¥ 16.42B | ¥ 14.30B | ¥ 12.63B | ¥ 11.52B | ¥ 9.84B | |
| Depreciation and Amortization | ¥ 0.00 | ¥ 3.96B | ¥ 3.68B | ¥ 3.02B | ¥ 2.75B |
| ¥ 6.36B | ¥ 8.96B | ¥ 7.56B | ¥ 6.88B | ¥ 6.52B | |
| ¥ 6.36B | ¥ 4.99B | ¥ 3.88B | ¥ 3.86B | ¥ 3.78B | |
| ¥ -3.20B | ¥ -990.00M | ¥ 4.39B | ¥ 540.00M | ¥ -55.00M | |
| ¥ 3.15B | ¥ 4.00B | ¥ 8.28B | ¥ 4.40B | ¥ 3.72B | |
| ¥ 2.83B | ¥ 3.00B | ¥ 6.15B | ¥ 3.44B | ¥ 2.70B | |
| Per Share Metrics | |||||
| Basic EPS | ¥ 111.18 | ¥ 122.93 | ¥ 252.81 | ¥ 141.35 | ¥ 110.98 |
| Diluted EPS | ¥ 111.18 | ¥ 122.93 | ¥ 252.81 | ¥ 141.35 | ¥ 110.98 |
| Weighted Average Shares Outstanding | 25.46M | 24.40M | 24.31M | 24.30M | 24.29M |
| Weighted Average Shares Outstanding (Diluted) | 25.46M | 24.40M | 24.31M | 24.30M | 24.29M |
Currency in JPY

